# FDA Inspection 1187532 - Sarah Leary, M.D. - October 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/sarah-leary-md/336c7c38-e658-4db1-b4b6-41f85aa7a715
Source feed: FDA_Inspections

> FDA Inspection 1187532 for Sarah Leary, M.D. on October 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187532
- Company Name: Sarah Leary, M.D.
- Inspection Date: 2022-10-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/sarah-leary-md/8e83f962-6903-476f-aa1d-7a028a8b5e24

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c